No surprise here...

Highest Debt to Asset Ratio in the Biotechnology Industry Detected in Shares of Anavex Life Sciences (AVXL, TLON, UGNE, MNKD, NGSX)

Apr 12, 2012 (SmarTrend(R) News Watch via COMTEX) -- Below are the three companies in the Biotechnology industry with the highest debt to asset ratios. The Debt/Asset ratio shows the proportion of a company's assets that are financed through debt. If the ratio is greater than one, most of the company's assets are financed through debt.Anavex Life Sciences ranks highest with a a debt to asset ratio of 13.67. Talon Therapeutics is next with a a debt to asset ratio of 4.21. Unigene Laboratories ranks third highest with a a debt to asset ratio of 2.84.

Story continues below ↓

"MannKind follows with a a debt to asset ratio of 2.44, and NeurogesX rounds out the top five with a a debt to asset ratio of 1.72.

SmarTrend recommended that its subscribers protect gains by selling shares of Unigene Laboratories on February 28th, 2012 by issuing a Downtrend alert when the shares were trading at $0.49. Since that call, shares of Unigene Laboratories have fallen 15.5%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

http://financial.tmcnet.com/news/2012/04/12/6254571.htm